← All PFAS health conditions

Hodgkin Lymphoma and PFAS Exposure

Hodgkin lymphoma is a cancer of the lymphatic system that is reviewed in PFAS matters where a documented exposure history and clear medical records exist. It is distinguished from non-Hodgkin lymphoma by the presence of Reed-Sternberg cells on pathology.

Do I have a hodgkin lymphoma PFAS claim?

There is no way to answer that from a web page alone, but these are the facts a Pennsylvania hodgkin lymphoma PFAS claim review actually turns on. If most of them describe your situation, it is worth submitting the intake form.

  • A confirmed hodgkin lymphoma diagnosis, documented by pathology or an oncology record.
  • A PFAS exposure source you can point to — a public water system, a private well, AFFF firefighting foam, a military base, an airport, or an industrial workplace.
  • Time spent at that location: where you lived, worked, or served, and roughly which years.
  • Diagnosis timing that follows the exposure period, which is what links the two in a claim review.
  • Any supporting paperwork — water-test results, utility bills, employment records, or military service records tying you to the location.

Representation of accepted cases is typically on a contingency-fee basis — no attorneys’ fees unless a recovery is obtained. Clients may remain responsible for case costs and expenses; the written retainer will set out how costs are handled. No case outcome is guaranteed.

PFAS linkage

  • PFAS accumulate in blood and are studied for effects on the immune system, which is the system Hodgkin lymphoma arises from.
  • Immune-system effects are among the health outcomes most consistently reported in PFAS research, including reduced vaccine response in exposed populations.
  • Evidence tying PFAS specifically to Hodgkin lymphoma is less developed than for kidney or testicular cancer, so intake review weighs exposure documentation, duration, and diagnosis details closely.
  • Cases most often reviewed involve long-term contaminated drinking water, AFFF firefighting foam at military or airport sites, or industrial PFAS handling.

Hodgkin lymphoma symptoms

  • Painless swelling of lymph nodes in the neck, armpit, or groin
  • Persistent fever, drenching night sweats, or unexplained weight loss (B symptoms)
  • Ongoing fatigue or itching without a skin condition to explain it
  • Chest discomfort, cough, or shortness of breath from enlarged nodes in the chest
  • Pain in lymph nodes after drinking alcohol, an uncommon but recognized sign

Diagnosis and medical records

  • Excisional lymph node biopsy with pathology review identifying Reed-Sternberg cells
  • Blood counts, sedimentation rate, and metabolic panels
  • PET-CT and CT imaging for staging
  • Bone marrow evaluation in selected cases

Treatment options

  • Combination chemotherapy regimens such as ABVD, often with response-adapted adjustment
  • Radiation therapy for limited-stage or bulky disease
  • Targeted therapy such as brentuximab vedotin or checkpoint inhibitors in selected cases
  • Stem cell transplant for relapsed or refractory disease
  • Long-term survivorship monitoring for late treatment effects

What patients should gather for intake

  • Keep the biopsy pathology report — it distinguishes Hodgkin from non-Hodgkin lymphoma and is central to review.
  • Record every Pennsylvania address, employer, military base, fire-training site, or water system connected to your exposure years.
  • Preserve well-test results, water-authority notices, and any PFAS or PFOA letters you received.
  • Note your age at diagnosis, stage, and treatment history including transplant.

Medical and attorney advertising notice. This page is for general information only and is not medical advice. Talk with your treating clinician about diagnosis and treatment. Submitting an intake form does not create an attorney-client relationship, and cases may be referred to national PFAS co-counsel.

Frequently Asked Questions

Hodgkin lymphoma and PFAS exposure FAQs

Is Hodgkin lymphoma part of PFAS litigation?
Hodgkin lymphoma is reviewed on a case-by-case basis. It is not among the cancers with the strongest published PFAS association, so the intake team looks closely at the strength of the exposure record and the medical documentation.
How is this different from non-Hodgkin lymphoma?
The two are separate diagnoses distinguished by pathology. Non-Hodgkin lymphoma appears more often in PFAS claim review, so it is important that your submission reflects exactly what your pathology report says.
Can I submit the form if I am unsure which PFAS source affected me?
PFAS cases depend on the diagnosis, exposure pathway, timing, residence or work history, and available water or site records. The intake form helps the review team evaluate those facts confidentially.
Related Cancer Pages

Other PFAS-linked cancers under review